TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Bure Equity AB ( (SE:BURE) ) has shared an update.
Bure Equity AB, a Swedish investment company, reported a challenging financial performance for the first nine months of 2025, with a 17.5% decrease in net asset value per share and a total return on shares of -26.7%. Despite some stabilization in the third quarter, the company faced currency struggles and lower growth, impacting its portfolio companies. Key activities included the acquisition of a stake in Silex Microsystems and divestments in Mycronic and Ovzon. The CEO noted both positive developments in companies like Vitrolife and challenges such as Yubico’s unmet expectations.
The most recent analyst rating on (SE:BURE) stock is a Hold with a SEK296.00 price target. To see the full list of analyst forecasts on Bure Equity AB stock, see the SE:BURE Stock Forecast page.
More about Bure Equity AB
Average Trading Volume: 55,847
Technical Sentiment Signal: Hold
Current Market Cap: SEK19.86B
See more data about BURE stock on TipRanks’ Stock Analysis page.